← Back to all trials
Recruiting
NCT05669248
A Follow-up Study of Immune Dysregulation in Patients With COVID-19
Conditions: COVID-19, Immunosuppression
Sex: All
Ages: 18 Years – N/A
Enrollment: 200
Sponsor: Qilu Hospital of Shandong University
Location: China
Summary
In order to detect the immunosuppression status of COVID-19 patients, this study collected blood samples of COVID-19 patients on the 10th, 20th and 30th days after the onset of symptoms, and detected the proinflammatory, anti-inflammatory factors，immunosuppressive marker，immune cells in the blood samples to evaluate the immunosuppression status of COVID-19 patients.
Eligibility Criteria
Inclusion Criteria:Participant is diagnosed with symptomatic COVID-19 by a positive PCR for SARS-CoV-2 or antigen quicktest.Study participant is 18 years of age or olderExclusion Criteria:Patients with immunosuppression, including HIV infection, hematopoietic stem cell transplantation and high-dose immunosuppressant therapyPregnancy or breastfeedingPatients receiving chemotherapy or other cancer treatment
Source: ClinicalTrials.gov (NCT05669248). StuddyBuddy aggregates publicly available trial information.
